News By Tag
* Cancer Drugs
* Breast Cancer
* Lung Cancer
* More Tags...
News By Location
Chemo101.com launches as Innovative Chemotherapy Education Website
Chemo101.com, a new educational website for cancer patients, made its official launch. Chemo101 is an innovative and comprehensive new platform that provides those undergoing chemotherapy treatments.
Says Gustafson, President and founder of Chemo101, "Now cancer patients and caregivers will have their own comprehensive site to get the latest information on all matters related to the chemotherapy experience. For years we've been listening closely to healthcare providers and patients share their personal challenges in managing the physical and financial impact of cancer treatments. Many patients have to stop or alter therapy due to unforeseen side effects or escalating treatment costs. We've made it our goal to help patients access critical information about their treatments and financial options in a simple and concise way that will allow them to take more control in the decision making process. What makes Chemo101 unique to other resources is that we have incorporated learning principles that will help individuals with varying backgrounds better understand the information. It’s an information source that’s reliable, user-friendly and of true value”
Chemo101 is accessible online in beta format at www.Chemo101.com. Patients, caregivers, and healthcare providers can log on to review this new resource and provide feedback.
Chemo101 is a Denver, CO based organization focused on providing educational resources for cancer patients and caregivers, and patient management solutions for healthcare professionals. Chemo101 is also the administrator of Chemo101Gives, a 501 (c) (3) pending non-profit, dedicated to providing financial support for the non-medical needs of cancer patients.
# # #
Chemo101.com is an interactive website dedicated to cancer patients and caregiver. Chemo101 provides cancer stricken patients and their caregivers with educational and practical information.